The Role of Biologics Agent in the Treatment of Inflammatory Bowel Disease

Abstract: Inflammatory bowel disease (IBD), with major manifestations as Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic intestinal inflammatory disorder with an unknown etiology which pathogensis involving multifactorial immune disorder characterized by chronic relapsing inflammation of the intestine. Management of IBD depends on stage and location of the inflammation consist of the classic conventional treatment and the more new treatment with biologics agent. Biologics agent refers to monoclonal antibodies with activity directed against specific targets involved in the pathogenesis of chronic inflammatory conditions. Advances in the understanding of the specific mechanisms of pathogenesis IBD led to the development of targeted treatment. Today there are six biologics agent approved and used as therapy and there still many other biologics agent on research progress. Many reports show positive report about efficacy for the biological therapy compared with placebo and conventional treatment for the IBD. Limited by their cost and adverse effect that possibly happened, biologics agent is still promising therapy that change the course of IBD treatment.

Keyword: Inflammatory bowel disease (IBD); Crohn’s disease (CD); ulcerative colitis (UC); biological therapy; biologics agent

Author: Tri Hapsoro Guno, Marcellus Simadibrata

Journal Code: jpkedokterangg170395

Artikel Terkait :

Jp Kedokteran gg 2017

• Disseminated Histoplasmosis in an Indonesian HIV-Positive Patient: A Case Diagnosed by Fine Needle Aspiration Cytology
• ST Elevation in Lead aVR and Its Association with Clinical Outcomes
• A Rare Case Series of Ischemic Stroke Following Russell’s Viper Snake Bite in India
• Current and Emerging Therapy on Lupus Nephritis
• Dengue Hemorrhagic Fever with Acute Fulminant Hepatitis: A Case Report
• Intralesion Triamcinolon Injection Therapy on Esophageal Stricture as Side Effect of Long Term Use Biphosphonate
• Alcoholic Liver Cirrhosis in Young Female: Diagnostic and Therapeutic Challenge
• Long Term Risks of Proton Pump Inhibitor Administration: A Literature Review
• Artificial Ascites in Radiofrequency Ablation for Liver Cancer
• Celiac Disease
• Correlation of Aerobic Exercise and High Nitrate Diet with Population of Eschericia coli in the Digestive Tract of Liver Cirrhosis Individuals
• Incidence of Colorectal Cancer in Saiful Anwar Hospital, Malang January 2010- April 2015
• The Comparison of Tnf α (Tumor Necrosis Factor α) Serum Levels Between Cytotoxin - Associated Gene A (Caga) Positive and Negative in Patients with Gastritis Helicobacter pylori
• Serial Case: Colorectal Malignancy in Young Age
• Diagnostic Findings of Sclerosing Mesenteritis and the Disease Correlations with Caecal Adenocarcinoma
• Small Bowel Malignancy in Patient with Obscure Gastrointestinal Bleeding in Cipto Mangunkusumo Hospital, Diagnosed Using Double Balloon Enteroscopy: A Case Series
• Precancerous Lesions in Gastrointestinal Tract
• National Consensus on the Use of Sedation Drugs in the Gastrointestinal Endoscopic Procedures
• Hepatitis B Reactivation in Immunosupressed Patients, Prophylaxis and Management
• The Association between Metaplasia and Gastric Malignancy with Helicobater pylori Infection
• Correlation of Carcinoma Percentage (CP) in Colorectal Adenocarcinoma with Several Clinical Pathological Aspects in Anatomical Pathology Department Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital Jakarta in Year 2012-2013
• Association Between Degree of Gastritis and Malondialdehyde Level of Gastritis Patients at Adam Malik General Hospital Medan
• Microscopic Examination of Fecal Leukocytes as a Simple Method to Detecting Infective Colitis in Children
• Successful Therapy in A 20 Years Old Male with Acute Pancreatitis